跳至主要内容
临床试验/CTRI/2019/07/020458
CTRI/2019/07/020458已完成4 期

AN OPEN LABEL, OBSERVATIONAL, PROSPECTIVE, NON-COMPARATIVE,MULTICENTRE STUDY TO EVALUATE EFFECTIVENESS AND TOLERABILITY OFMOISTURISER IN ACNE PATIENTS WHO ARE PRESCRIBED ISOTRETINOIN - Complement

Cipla Ltd0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
Cipla Ltd
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1. A voluntarily given, written signed dated data sharing consent from participants and/or legally acceptable representative.
  • 2. Participants of 18 years and above of either gender who are newly prescribed Isotretinoin or who have not used oral isotretinoin for past one month for the management of acne and moisturiser (Excela) as an adjuvant therapy as per Investigatorââ?¬•s discretion.

排除标准

  • 1.Any skin allergy or serious skin condition or unsuitable to participate in the study as per routine clinical practice.
  • 2.Pregnant and lactating women
  • 3.Participated in any clinical trial within 1 month from screening

研究者

发起方
Cipla Ltd

相似试验